Login
$LAB
$0.60 -$0.11 (15.04%) Live

$LAB 8-K/A SEC Filings

Filed On Filing
29 Jul 2026 8-K/A: Financial Statements and Exhibits

CERTAIN INFORMATION CONTAINED IN THIS AGREEMENT HAS BEEN OMITTED BY MEANS OF REDACTING A PORTION OF THE TEXT AND REPLACING IT WITH [***] BECAUSE IT IS BOTH: (I) NOT MATERIAL AND (II) THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONF...

05 Feb 2026 8-K/A: Financial Statements and Exhibits

On January 30, 2026, Standard BioTools Inc. (the "Company") completed the sale of all of the equity interests of SomaLogic, Inc. (“SomaLogic”), Sengenics Corporation LLC, and Sengenics Corporation Pte Ltd (collectively, the "Disposed Ent...

19 Jan 2024 8-K/A: Financial Statements and Exhibits

To the Stockholders and the Board of Directors of SomaLogic, Inc.

11 Feb 2022 8-K/A: Financial Statements and Exhibits

THIS LOAN AGREEMENT (this “Agreement”) dated and effective as of January 23, 2022 (the “Effective Date”) between CASDIN PARTNERS MASTER FUND, L.P., a Cayman Islands exempted limited partnership (“Master Fund”), CASDIN PRIVATE GROWTH EQUI...

06 Sep 2019 8-K/A: Departure/Election of Directors or Officers; Compensation

As reported in the Original Filing, on July 23, 2019, Bill W. Colston, Ph.D., was appointed a Class I director by the Board of Directors of Fluidigm Corporation. At the time of the Original Filing, the Board had not made a determination ...

02 Aug 2019 8-K/A: Results of Operations and Financial Condition

Expansion of Mass Cytometry Products with New Metal Markers and Imaging Mass Cytometry Panel Kits, Advanced CyTOF Software

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support